Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
Open Access
- 3 August 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (4), 2001935
- https://doi.org/10.1183/13993003.01935-2020
Abstract
Helmet CPAP treatment fails in up to 44% of patients with moderate-to-severe hypoxaemic acute respiratory failure due to COVID-19 pneumoniahttps://bit.ly/3g7FAB8This publication has 11 references indexed in Scilit:
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19The New England Journal of Medicine, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy ProposalJournal of Clinical Medicine, 2020
- Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: from ward to trenchesEuropean Respiratory Journal, 2020
- Protecting healthcare workers from SARS-CoV-2 infection: practical indicationsEuropean Respiratory Review, 2020
- Management of Critically Ill Adults With COVID-19JAMA, 2020
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Non-invasive positive pressure ventilation in pneumonia outside Intensive Care Unit: An Italian multicenter observational studyEuropean Journal of Internal Medicine, 2018
- Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumoniaIntensive Care Medicine, 2014
- Helmet Continuous Positive Airway Pressure vs Oxygen Therapy To Improve Oxygenation in Community-Acquired PneumoniaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010